Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

ANASTROZOLE 1 MG TABLET

Anastrozole Tablets
$0.1631per EA

Strength

1 mg/1

Manufacturer

Yiling Pharmaceutical Inc.

NDC

69117000301

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

8/23/2023

Active Ingredients

ANASTROZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA206037

On Market Since

2/28/2019

Pharmacological Classes

Aromatase Inhibitor
Aromatase Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

+32.7%

5Y

+17.1%

All

+15.8%

Generic Alternatives

Save up to 16%

1 alternative • Same active ingredient

ANASTROZOLE 1 MG TABLET
Generic
23155085703•Avet Pharmaceuticals Inc.
$0.1376
Save 16%

Related Drugs

Same classification

LETROZOLE 2.5 MG TABLET
Generic
69117000401•Yiling Pharmaceutical Inc.
$0.1203
per EA
ANASTROZOLE 1 MG TABLET
Generic
68382020910•Zydus Pharmaceuticals (USA) Inc.
$0.1366
per EA
ANASTROZOLE 1 MG TABLET
Generic
00093753656•Teva Pharmaceuticals USA Inc.
$0.1376
per EA
ANASTROZOLE 1 MG TABLET
Generic
16729003510•Accord Healthcare Inc.
$0.1376
per EA
ANASTROZOLE 1 MG TABLET
Generic
16729003515•Accord Healthcare Inc.
$0.1376
per EA
ANASTROZOLE 1 MG TABLET
Generic
16729003516•Accord Healthcare Inc.
$0.1376
per EA
ANASTROZOLE 1 MG TABLET
Generic
50268007515•AvPAK
$0.1376
per EA
ANASTROZOLE 1 MG TABLET
Generic
51991062010•Breckenridge Pharmaceutical Inc.
$0.1376
per EA
ANASTROZOLE 1 MG TABLET
Generic
51991062033•Breckenridge Pharmaceutical Inc.
$0.1376
per EA
ANASTROZOLE 1 MG TABLET
Generic
51991062090•Breckenridge Pharmaceutical Inc.
$0.1376
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy